Medtronic expects its fiscal 2025 third-quarter revenues to reflect an unfavorable impact of 1% from currency translation.

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

Insulin pump therapy, also known as continuous subcutaneous ... reports on the US Food and Drug Administration's Manufacturer and User Facility Device Experience (MAUDE) database is potentially ...

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

After hours: 7 February at 7:52:49 pm GMT-5 ...

DiveWire guarantees visibility for your news announcements through instant distribution to MedTech Dive’s audience and its 60,000 newsletter subscribers for 21 days.

2-Year U.S. Treasury Note Continuous Contract $102.730-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $106.453-0.023-0.02% 10-Year U.S. Treasury Note Continuous Contract $109.188-0.031 ...

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its Hugo surgical robot.